Purchase Order 75N91020P00317

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biological kits valued at $14,923.40 on August 24, 2020, with an ultimate completion date of September 23, 2020. Place of performance is Carlsbad, California. The order carries firm fixed pricing with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation on February 11, 2020, for drugs and biologicals with a ceiling value of $15,081.95. Place of performance is Grand Island, New York. The order is firm fixed price with an ultimate completion date of March 31, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation on August 5, 2015, valued at $3,011.04 for scientific instruments, reagents, or consumables with a firm fixed price structure. Performance occurred in Baltimore, Maryland, with an ultimate completion date of September 28, 2016. No set-aside applied to this simplified acquisition.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $3,516.74 on January 8, 2016, for firm fixed price commercial items with an ultimate completion date of October 31, 2016. Performance is located in Carlsbad, California. No set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $7,821.75 on March 14, 2019, with an ultimate completion date of March 14, 2020. The order is firm fixed price with no set-aside designation. Place of performance is Gaithersburg, Maryland. The purchase order was issued to de-obligate funds from FY2019 expiring lines in accordance with NIH Office of Administrative Law and Management communication.</p>

The National Cancer Institute awarded a $19,905 firm fixed-price purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on December 2, 2024, with an ultimate completion date of November 1, 2025. This contract is part of the FY26 UDO Initiative and was issued without set-aside designation, reflecting open competitive procurement. Life Technologies Corporation, headquartered in Carlsbad, California, is a leading supplier of scientific instrumentation, reagents, and...

<p>The National Cancer Institute issued a purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) valued at $10,412.00 on July 1, 2020, for biological kits. Place of performance is Carlsbad, California. The order is firm fixed price with an ultimate completion date of July 31, 2020. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $20,283.34 on April 24, 2020, for a service agreement with a firm fixed price. Work is performed in Bethesda, Maryland. The order is set to complete by July 19, 2020.</p>

<p>The National Cancer Institute issued a $17,792.10 delivery order to Illumina, Inc. on January 13, 2020, for reagents and consumables.</p> <p>Place of performance is Bethesda, MD 20892. Ultimate completion date is February 12, 2020. The order is firm fixed price with no set-aside designation.</p>